๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

An immunomodulating drug, thymopentin, in the treatment of progressive systemic sclerosis

โœ Scribed by N. Giordano; G. Biasi; A. Taddeo; R. Marcolongo; D. Bertelletti

Publisher
Springer
Year
1989
Tongue
English
Weight
120 KB
Volume
8
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Plasma exchange in the treatment of nona
Plasma exchange in the treatment of nonadvanced stages of progressive systemic sclerosis
โœ G. Mascaro; G. Cadario; G. Bordin; M. Tarditi; G. Ferraris; Anna Monteverde; L. ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 572 KB

Ten patients suffering from progressive systemic sclerosis, who responded poorly to conventional therapy, underwent plasma exchange (PE) therapy in conjunction with drug therapy. The frequency of PE was twice weekly for 4-6 weeks. two or three times per year, with a summer interruption, when in our

Fixation of S35 in the skin of patients
Fixation of S35 in the skin of patients with progressive systemic sclerosis
โœ Charles W. Denko; Richard B. Stoughton ๐Ÿ“‚ Article ๐Ÿ“… 1958 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 303 KB ๐Ÿ‘ 2 views

## Abstract A preliminary study of the fate of radioactive sulfur (Na~2~S^35^O~4~) given intravenously to patients with progressive systemic sclerosis has revealed an appreciably greater radioactivity in the involved skin. The evidence presented suggests an abnormal rate of uptake of sulfur in the